Jundishapur Journal of Microbiology

Published by: Kowsar

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Gene Polymorphisms and Hepatitis B Virus Infection

Anvar Soleimani 1 , Houshang Rafatpanah 2 , Amin Reza Nikpoor 3 , Mehrdad Kargari 4 and Daryoush Hamidi Alamdari 5 , *
Authors Information
1 Department of Clinical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Inflammation and Inflammatory Diseases Research Centre, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Department of Immunogenetic and Cell Culture, Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Department of Basic Medical Science, Neyshabur University of Medical Sciences, Neyshabur, IR Iran
5 Biochemistry and Nutrition Research Center, Department of Clinical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Microbiology: November 01, 2015, 8 (11); e23578
  • Published Online: November 14, 2015
  • Article Type: Research Article
  • Received: September 25, 2014
  • Revised: February 26, 2015
  • Accepted: June 28, 2015
  • DOI: 10.5812/jjm.23578

To Cite: Soleimani A, Rafatpanah H, Nikpoor A R, Kargari M, Hamidi Alamdari D. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Gene Polymorphisms and Hepatitis B Virus Infection, Jundishapur J Microbiol. 2015 ; 8(11):e23578. doi: 10.5812/jjm.23578.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005; 5(3): 215-29[DOI][PubMed]
  • 2. Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol. 2007; 85(1): 16-23[DOI][PubMed]
  • 3. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012; 142(6): 1264-1273 e1[DOI][PubMed]
  • 4. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon. 2008; 8(4): 281-94
  • 5. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 6. Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008; 12(3): 378-82[DOI][PubMed]
  • 7. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 1995; 3(6): 673-82[PubMed]
  • 8. MacFarlane M. TRAIL-induced signalling and apoptosis. Toxicol Lett. 2003; 139(2-3): 89-97[PubMed]
  • 9. Gray HL, Sorensen EL, Hunt JS, Ober C. Three polymorphisms in the 3' UTR of the TRAIL (TNF-related apoptosis-inducing ligand) gene. Genes Immun. 2001; 2(8): 469-70[DOI][PubMed]
  • 10. Baetu TM, Hiscott J. On the TRAIL to apoptosis. Cytokine Growth Factor Rev. 2002; 13(3): 199-207[PubMed]
  • 11. Kimberley FC, Screaton GR. Following a TRAIL: update on a ligand and its five receptors. Cell Res. 2004; 14(5): 359-72[DOI][PubMed]
  • 12. Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases. Hum Pathol. 2005; 36(10): 1066-73[DOI][PubMed]
  • 13. Mundt B, Kuhnel F, Zender L, Paul Y, Tillmann H, Trautwein C, et al. Involvement of TRAIL and its receptors in viral hepatitis. FASEB J. 2003; 17(1): 94-6[DOI][PubMed]
  • 14. Strater J, Moller P. TRAIL and viral infection. Vitam Horm. 2004; 67: 257-74[DOI][PubMed]
  • 15. Han LH, Sun WS, Ma CH, Zhang LN, Liu SX, Zhang Q, et al. Detection of soluble TRAIL in HBV infected patients and its clinical implications. World J Gastroenterol. 2002; 8(6): 1077-80[PubMed]
  • 16. Jung YJ, Kim YJ, Kim LH, Lee SO, Park BL, Shin HD, et al. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection. Intervirology. 2007; 50(5): 369-76[DOI][PubMed]
  • 17. Schork NJ, Fallin D, Lanchbury JS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet. 2000; 58(4): 250-64[PubMed]
  • 18. Lian JQ, Yang XF, Zhao RR, Zhao YY, Li Y, Zhang Y, et al. Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection. Hepat Mon. 2014; 14(6)[DOI][PubMed]
  • 19. Kikuchi S, Miyagishi R, Fukazawa T, Yabe I, Miyazaki Y, Sasaki H. TNF-related apoptosis inducing ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunol. 2005; 167(1-2): 170-4[DOI][PubMed]
  • 20. Mi Y, Zhu L, Feng N. Polymorphism Analysis of TRAIL Gene and Correlation TRAIL Expression in Prostate Cancer. 2011;
  • 21. Wang C, Xu S, Yi F, Wang X, Lei Y, Huang S, et al. Tumor necrosis factor-related apoptosis inducing ligand gene polymorphisms are correlated with gastric cancer in central China. Pharm Res. 2015; 32(3): 762-8[DOI][PubMed]
  • 22. Yan X, Xu L, Qi J, Liang X, Ma C, Guo C, et al. sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease. Immunogenetics. 2009; 61(8): 551-6[DOI][PubMed]
  • 23. Yu MY, Zhao PQ, Yan XH, Liu B, Zhang QQ, Wang R, et al. Association between the TRAIL single nucleotide polymorphism rs1131580 and type 2 diabetes mellitus in a Han Chinese population. Genet Mol Res. 2013; 12(3): 3455-64[DOI][PubMed]
  • 24. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol. 2006; 87: 1439-49[DOI][PubMed]
  • 25. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology. 2003; 38(1): 4-13[DOI][PubMed]
  • 26. Ulevitch RJ, Mathison JC, da Silva Correia J. Innate immune responses during infection. Vaccine. 2004; 22 Suppl 1-30[DOI][PubMed]
  • 27. Wajant H. CD95L/FasL and TRAIL in tumour surveillance and cancer therapy. Cancer Treat Res. 2006; 130: 141-65[PubMed]
  • 28. Liang X, Liu Y, Zhang Q, Gao L, Han L, Ma C, et al. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J Immunol. 2007; 178(1): 503-10[PubMed]
  • 29. Saadatian Z, Masotti A, Nariman Saleh Fam Z, Alipoor B, Bastami M, Ghaedi H. Single-Nucleotide Polymorphisms Within MicroRNAs Sequences and Their 3' UTR Target Sites May Regulate Gene Expression in Gastrointestinal Tract Cancers. Iran Red Crescent Med J. 2014; 16(7)[DOI][PubMed]
  • 30. Motavaf M, Safari S, Alavian SM. Interleukin 18 gene promoter polymorphisms and susceptibility to chronic hepatitis B infection: a review study. Hepat Mon. 2014; 14(7)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments